Field Trip Health Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FTRP research report →
Companywww.fieldtriphealth.com
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.
- IPO
- 2020
- Employees
- 194
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $9.81M
- P/E
- -0.14
- P/S
- 2.77
- P/B
- 0.11
- EV/EBITDA
- 0.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -88.27%
- Op Margin
- -1102.78%
- Net Margin
- -1147.88%
- ROE
- -61.81%
- ROIC
- -55.82%
Growth & Income
- Revenue
- $4.86M · 405.78%
- Net Income
- $-55,787,000 · -141.31%
- EPS
- $-8.44 · -141.14%
- Op Income
- $-53,595,000
- FCF YoY
- -152.91%
Performance & Tape
- Beta
- 0.00
Get TickerSpark's AI analysis on FTRP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FTRP Coverage
We haven't published any research on FTRP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FTRP Report →